Scopus BioPharma Inc. (SCPS)
OTCMKTS: SCPS · Delayed Price · USD
0.0002
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
Scopus BioPharma Employees
Scopus BioPharma had 13 employees as of December 31, 2022. The number of employees increased by 4 or 44.44% compared to the previous year.
Employees
13
Change (1Y)
4
Growth (1Y)
44.44%
Revenue / Employee
n/a
Profits / Employee
-$668,910
Market Cap
8.42K
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 13 | 4 | 44.44% |
Dec 31, 2021 | 9 | 8 | 800.00% |
Dec 31, 2020 | 1 | 0 | - |
Dec 31, 2019 | 1 | 0 | - |
Dec 31, 2018 | 1 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
SCPS News
- 9 months ago - Scopus BioPharma's Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer - GlobeNewsWire
- 9 months ago - Scopus BioPharma's Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer - GlobeNewsWire
- 1 year ago - Scopus BioPharma's Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of Cancer - GlobeNewsWire
- 1 year ago - Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Value - GlobeNewsWire
- 2 years ago - Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors - GlobeNewsWire
- 2 years ago - Scopus BioPharma's Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies Summit - GlobeNewsWire
- 2 years ago - Scopus BioPharma Provides Update Following Annual Meeting of Stockholders - GlobeNewsWire
- 2 years ago - DR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. - PRNewsWire